S, or multiple sclerosis, poses many problems not only from a diagnostic point of view, but also in terms of undertaking appropriate treatment. Studies are currently being conducted, the results of which prove the therapeutic efficacy of a substance that medicine already knows and uses extensively, namely rituximab. The conclusions of these studies indicate that it is a preparation that shows both high efficacy in the treatment of S, but also a high level of safety for the patient.